Showing results (161-170 of 752) with videos related to
Sort By:
Pageof 76
Current Treatment Options in Neurology|April 5, 2013
Treatment options in newly diagnosed glioblastomaEudocia Q Lee, Lakshmi Nayak, Patrick Y Wen, et al.The Oncologist|September 28, 2011
Discontinuing bevacizumab in patients with glioblastoma: an ethical analysisJennifer C Kesselheim, Andrew D Norden, Patrick Y Wen, et al.Hematology/Oncology Clinics of North America|November 10, 2021
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including GlioblastomaEvanthia Galanis, Patrick Y Wen, John F de Groot, et al.Journal of Neuro-Oncology|June 18, 2015
Radiotherapy and death from cerebrovascular disease in patients with primary brain tumorsAyal A Aizer, Rose Du, Patrick Y Wen, et al.Current Treatment Options in Neurology|September 16, 2010
Recurrent high-grade gliomaEudocia C Quant, Jan Drappatz, Patrick Y Wen, et al.Expert Review of Neurotherapeutics|March 28, 2012
A novel treatment for glioblastoma: integrin inhibitionMarc C Chamberlain, Timothy Cloughsey, David A Reardon, et al.Journal of Neuro-Oncology|June 18, 2010
Survival among patients with primary central nervous system lymphoma, 1973-2004Andrew D Norden, Jan Drappatz, Patrick Y Wen, et al.Cancer|December 22, 2017
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastomaDavid A Reardon, Andrew B Lassman, David Schiff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Phase II study of protracted daily temozolomide for low-grade gliomas in adultsSantosh Kesari, David Schiff, Jan Drappatz, et al.Expert Opinion on Biological Therapy|May 15, 2008
Cintredekin besudotox in treatment of malignant gliomaMelike Mut, Jonathan H Sherman, Mark E Shaffrey, et al.Pageof 76